Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Down 27.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Tandem Diabetes Care (TNDM)
10:36am, Monday, 21'st Jul 2025
The heavy selling pressure might have exhausted for Tandem Diabetes Care (TNDM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree
Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025
04:05pm, Tuesday, 01'st Jul 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
12:20pm, Tuesday, 01'st Jul 2025
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 +
10:51am, Monday, 23'rd Jun 2025
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pu
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated
Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?
12:37pm, Friday, 30'th May 2025
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock?
Should Tandem Diabetes Stock Stay in Your Portfolio Now?
07:40am, Thursday, 22'nd May 2025
Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations.
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up
09:06am, Friday, 02'nd May 2025
Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.
Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript
08:11pm, Wednesday, 30'th Apr 2025
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - President
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
08:05pm, Wednesday, 30'th Apr 2025
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
06:55pm, Wednesday, 30'th Apr 2025
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.63 per share a year ago.
What to Expect From These 3 MedTech Stocks This Earnings Season?
10:15am, Tuesday, 29'th Apr 2025
Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.
Reasons to Hold TNDM Stock in Your Portfolio for Now
10:01am, Thursday, 17'th Apr 2025
A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
04:00pm, Monday, 14'th Apr 2025
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
